Jamal El-Mosleh
Director Ejecutivo en ELICERA THERAPEUTICS AB .
Perfil
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB.
Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB.
He also served on the board at Elypta AB.
He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Cargos activos de Jamal El-Mosleh
| Empresas | Cargo | Inicio |
|---|---|---|
| ELICERA THERAPEUTICS AB | Director Ejecutivo | 01/01/2020 |
Antiguos cargos conocidos de Jamal El-Mosleh.
| Empresas | Cargo | Fin |
|---|---|---|
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | 01/01/2020 |
| ANNEXIN PHARMACEUTICALS AB | Director Ejecutivo | 01/01/2019 |
| MENDUS AB | Director Ejecutivo | 01/10/2016 |
Formación de Jamal El-Mosleh.
| Chalmers University of Technology | Graduate Degree |
| Chalmers School of Entrepreneurship | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MENDUS AB | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |
- Bolsa de valores
- Insiders
- Jamal El-Mosleh
